Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-20-001268
Filing Date
2020-02-14
Accepted
2020-02-13 19:51:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 d8476089_13g-a.htm SC 13G/A 142185
  Complete submission text file 0000919574-20-001268.txt   143809
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Subject) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88334 | Film No.: 20613012
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 WEST 55TH STREET FLOOR 16 NEW YORK NY 10004
Business Address 250 WEST 55TH STREET FLOOR 16 NEW YORK NY 10004 212-915-2565
LIFESCI INDEX PARTNERS LLC (Filed by) CIK: 0001734312 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A